Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .Jamie Dimon, the CEO of JPMorgan Chase & Co. ( JPM ) had some sage advice for prudent investors after the bank reported better-than-expected Q3 results last Tuesday. He noted that his bank took a $170 million chargeBret leads the invest ...

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Molina and certain of its o ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Trusting SPX Reversal? (Investorideas.com Newswire) S&P 500 short gains of over +100 ES points (and over +500 NDX pts) were made before the opening bell – and rebound‘s veracity made me still at the very beginning of the session conclude that Friday won‘t be a day of fresh retest of the lows, i.e. that the sellers wouldn‘t muster enough strength just yet. The strength demonstrated was though somewhat more than about bringing the buyers back into the game. This goes beyond consumer stocks (both discretio ...

Kenvue has urged U.S. regulators to reject a request for a warning of autism on its popular over-the-counter pain medication Tylenol for use during pregnancy, according to a petition. ...

Calgary, Alberta – October 20, 2025 – TheNewswire – nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE: NDAT) (OTCQB: NDATF) is pleased to announce the completion of the genetic swab and Questionnaire collection for two WHL-league teams of the three teams participating in the Epitome predictive analytics project. The third team is from the Ontario University Athletics (OUA) conference and its data collection is to begin before October 31 with closure expected prior to the end of November. The Corporation’s ...

Labutes IR is a Fund Manager/Analyst specialized in the financial sector, with more than 18 years of experience in the financial markets. I have worked at several type of institutions in the industry, always at the buy side and related to portfolio management. Associated with the existing author The Outsider.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this artic ...

This audio is auto-generated. Please let us know if you have feedback Dive Brief:The Lovesac Company, a direct-to-consumer furniture retailer, has made significant headway on a four-point plan to mitigate tariff costs, executives told investors.The strategy's components include negotiating concessions with long-term vendors, diversifying the supply base, raising prices and cutting costs throughout the business, President and COO Mary Fox said in a Sept. 11 earnings call."We believe that this four-point pla ...

Core Insights - Bloom Energy Corporation is engaging investors with a significant partnership with Brookfield Asset Management, aimed at transforming AI infrastructure [1][2] - The company is set to release its Q3 2025 financial results on October 28, with analysts predicting adjusted earnings of $0.091 and sales of $425.55 million [1] Partnership Details - Brookfield will invest $5 billion to deploy Bloom's technology, with global AI factory projects in progress, including a European site to be announced by year-end [2] - The collaboration aims to enhance AI factory design and power, leveraging Bloom's clean fuel cells and Brookfield's infrastructure expertise [2] Analyst Perspectives - Bank of America analyst Dimple Gosai views the partnership as a strategic win, enhancing Bloom's position in the AI-driven power sector, and has raised the price forecast from $24 to $26, maintaining an Underperform rating [3][4] - Initial deployments are expected to ramp up gradually, which may not significantly impact near-term earnings, but the stock's rally indicates investor optimism regarding future earnings potential [4] Earnings Expectations - The third-quarter earnings call is anticipated to focus on operational cadence and costs, with key updates expected on AEP order flow, Brookfield's first-site timeline, and Oracle Corp deployment [5] - Bloom Energy has reaffirmed its 2025 revenue guidance of $1.65 billion to $1.85 billion, with Bank of America forecasting $1.72 billion in revenue and $199 million in EBITDA at a 28.2% margin, which is below market expectations [6]

Core Insights - Apple shares reached an all-time high, indicating strong investor confidence and market performance [1] - The company is on the verge of becoming the third entity to achieve a $4 trillion market valuation, highlighting its significant market presence [1] - Recent data indicates robust momentum for the latest iPhone model, contributing to the surge in share prices [1] Company Performance - Apple shares surged to an all-time high on Monday [1] - The company is close to a $4 trillion market valuation [1] - Strong momentum for the latest iPhone has been reported [1]